Control of Emergence Blood Pressure During Craniotomy for Tumor Surgery Between Labetolol and Diltiazem

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 184 participants.

Also called NCT01408524

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 1/2
Enrolled
  • 184 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01408524
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01408524. Randomized; quadruple masking; primary purpose treatment. Start 2010-02 (registry gives no type); primary completion 2012-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Control of Emergence Blood Pressure During Craniotomy for Tumor Surgery Between Labetolol and Diltiazem
Condition
Hypertension
Condition
Craniotomy
Intervention (Drug)
Diltiazem
Intervention (Drug)
Labetalol
Lead sponsor
Mahidol University (class: other)

Record details

Record id
cardio:ct-nct01408524
Content hash
b1fedbbff168eefd3e27de29cfc9dfacdb458d63eaccfdc9f996cfbffd2f7746